EDGE a software system for the management of COPD.
EDGE is a software system for the management of COPD, developed by Oxford University Hospital and with support from the Department of Health.
EDGE has been shown to;
- Empowers patients to take control of their health from home
- Reduce the number of unnecessary hospital visits
- Enable nurses to care for the patients most in need
- Help to deliver care to people who live in remote and rural areas
- Supports patients to live independently
- Allows for better sharing of information to support integrated, joined-up, continuous care
Key features of the EDGE system include;
Tablet Technology :- EDGE uses state-of-the-art, multi-purpose Android tablet technology, with Bluetooth-enabled sensors.
Easy to use :- EDGE has no keyboard and uses large icons with bright colours for selecting menu options or answers to symptom diary questions, making it simple and easy to use.
Pulse Oximeter Probe :- EDGE patients are given a pulse oximeter finger probe to measure oxygen saturation levels easily.
Intelligent algorithms:- EDGE uses intelligent algorithms to improve patient compliance and medical adherence.
Simple self-management:- EDGE makes it easy for patients to self-manage their condition by giving them feedback on their physical well-being (through the use of graphs of their vital signs and symptom diary). It provides patients motivational and psychological support (e.g. through the use of videos and multi-media content).
Drayson Technologies has signed a five-year Strategic Research Agreement (SRA) with the University of Oxford (OU) and the Oxford University Hospitals NHS Foundation Trust (OUH). The OU and OUH have developed and trialled the technologies in the Oxford Biomedical Research Centre (BRC) funded by the National Institute for Health Research (NIHR).
The SRA and associated exclusive licensing arrangements ensure that the technologies can go into commercialisation stage so that they can bring benefit to patients across the NHS and overseas, and allows some of the profits to go back into the University of Oxford and the Oxford University Hospitals NHS Foundation Trust to fund more research and ultimately benefit more patients.